Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 14;37(6):497-502.
doi: 10.3760/cma.j.issn.0253-2727.2016.06.011.

[The prognostic significance of proportion of blasts in bone marrow on day 14 during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia]

[Article in Chinese]
Affiliations

[The prognostic significance of proportion of blasts in bone marrow on day 14 during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia]

[Article in Chinese]
J S Jia et al. Zhonghua Xue Ye Xue Za Zhi. .

Abstract

Objective: To investigate the prognostic significance of proportion of the blasts in bone marrow on day 14 (D14) during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia (Ph (-) ALL).

Methods: Newly diagnosed Ph (-) ALL patients with bone marrow morphology analysis on day 14 during induction chemotherapy were analyzed retrospectively. The proportion of the D14 blasts which had an impact on achieving a CR by the first induction chemotherapy and outcomes were determined by ROC curve.

Results: 166 ALL patients including 94 male and 72 female were analyzed. The median age was 32 years (range, 18-64 years). The CR rate by the first induction chemotherapy was 74.7% with a total CR rate as 93.3%. By ROC analysis, 7.5% of the D14 blasts had the best sensitivity and specificity. The patients with D14 blasts ≥7.5% had lower CR rates after the first and overall induction chemotherapy compared with those with D14 blasts <7.5% (42.7% vs 85.9%, P<0.001 and 75.9% vs 95.6%, P=0.001 respectively). The probabilities of 5-year disease free survival (DFS) and 5-year overall survival (OS) were higher in the patients with D14 blasts<7.5% than those with D14 blasts ≥7.5% (49.8% vs 29.6%, P=0.006 and 52.4% vs 32.6%, P=0.010 respectively). Multivariate analysis showed that higher WBC or central nervous system leukemia at diagnosis, D14 blasts ≥7.5%, no CR after the first induction chemotherapy and receiving consolidation and maintenance chemotherapy rather than transplant were associated with poor outcomes.

Conclusions: Higher proportion of D14 blasts in bone marrow during the first induction therapy indicated poor prognosis in adult Ph(-) ALL.

目的: 探讨成人Ph染色体阴性急性淋巴细胞白血病(PhALL)诱导治疗第14天(D14)骨髓原始细胞比例与获得完全缓解(CR)和预后的关系。

方法: 回顾分析166例初治PhALL患者,通过ROC曲线确定影响诱导治疗4周达CR的D14骨髓原始细胞比例。

结果: 166例PhALL患者,男94例,女72例,中位年龄32(18~64)岁。诱导治疗4周CR率为74.7%,总CR率为93.3%。存活者中位随访32(2~175)个月,5年无病生存(DFS)和总体生存(OS)率分别为45.6%和47.2%。D14骨髓原始细胞≥0.075组与<0.075组相比,4周CR率(42.7%对85.9%,P<0.001)和总CR率(75.9%对95.6%,P=0.001)显著降低,5年DFS率(29.6%对49.8%,P=0.006)和OS率(32.6%对52.4%,P=0.010)均显著降低。多因素分析显示,发病时高白细胞计数、存在中枢神经系统白血病、D14骨髓原始细胞≥0.075、诱导治疗4周未达CR、CR后接受化疗而非移植是影响DFS和OS的不利因素。

结论: 成人PhALL患者诱导化疗D14骨髓原始细胞比例较高是影响获得CR和总体预后的不利因素。

PubMed Disclaimer

Figures

图1
图1. 诱导治疗第14天骨髓原始细胞比例<0.075和≥0.075 Ph染色体阴性急性淋巴细胞白血病患者的生存曲线
A:全部患者;B:化疗组;C:移植组

Similar articles

References

    1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia[J] N Engl J Med. 2006;354(2):166–178. doi: 10.1056/NEJM-ra052603. - DOI - PubMed
    1. Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update[J] J Clin Oncol. 2011;29(5):551–565. doi: 10.1200/JCO.2010.30.7405. - DOI - PMC - PubMed
    1. 中华医学会血液学分会, 中国抗癌协会血液肿瘤专业委员会. 中国成人急性淋巴细胞白血病诊断与治疗专家共识[J] 中华血液学杂志. 2012;33(9):789–792. doi: 10.3760/cma.j.issn.0253-2727.2012.09.028. - DOI - PubMed
    1. Alvarnas JC, Brown PA, Advani A, et al. NCCN clinical practice guidelines in oncology. Acute lymphoblastic leukemia. National Comprehensive Cancer Network, Inc; 2016. Version 1. - PubMed
    1. Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial[J] Blood. 2007;109(8):3189–3197. doi: 10.1182/blood-2006-10-051912. - DOI - PubMed